Clinical Trial Update: A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece

View source ↗

Summary

This is a clinical trial update for a study of venetoclax in Chronic Lymphocytic Leukemia conducted in Greece. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Venclyxto (Venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Chronic Lymphocytic Leukemia | Status: ACTIVE_NOT_RECRUITING